Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      GSK Consumer Healthcare appoints Filippo Lanzi as APAC head

      GSK Consumer Healthcare appoints Filippo Lanzi as APAC head

      Ruby Khatun Khatun17 Jan 2018 10:30 AM IST
      New Delhi: GSK Consumer Healthcare said it has appointed Filippo Lanzi as Regional Head of Asia Pacific region.He replaces Zubair Ahmed who takes over...
      Sun Pharma settles patent litigation with Ironwood, Allergan

      Sun Pharma settles patent litigation with Ironwood, Allergan

      Ruby Khatun Khatun17 Jan 2018 10:00 AM IST
      New Delhi: Drug major Sun Pharma said it has settled a patent litigation with Ironwood Pharmaceuticals Inc and Allergan plc in the US over a generic...
      FDA to speed review of medical products for use by military

      FDA to speed review of medical products for use by military

      Ruby Khatun Khatun17 Jan 2018 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) and Department of Defense launched a program on Tuesday to speed the development and review of medical...
      Drugmaker Dermapharm gears up for likely first German IPO of 2018

      Drugmaker Dermapharm gears up for likely first German IPO of 2018

      Ruby Khatun Khatun17 Jan 2018 9:30 AM IST
      FRANKFURT: German drugmaker Dermapharm is preparing for an initial public offering (IPO), probably stealing a march on much larger Siemens’ healthcare...
      FDC Ban: Drugs Technical Advisory Board to review efficacy, safety, justification of drugs

      FDC Ban: Drugs Technical Advisory Board to review efficacy, safety, justification of drugs

      Ruby Khatun Khatun16 Jan 2018 5:13 PM IST
      New Delhi: The Drugs Technical Advisory Board (DTAB) is expected to set up expert committees to review the safety, efficacy and therapeutic...
      Lupin forays into OTC segment, eyes Rs 300 crore turnover in 5 years

      Lupin forays into OTC segment, eyes Rs 300 crore turnover in 5 years

      Ruby Khatun Khatun16 Jan 2018 11:30 AM IST
      New Delhi: Drug major Lupin said it has forayed into over-the-counter (OTC) segment in the country with plans to touch Rs 300 crore turnover in the...
      Glenmark gets nod for phase II study of novel molecule

      Glenmark gets nod for phase II study of novel molecule

      Ruby Khatun Khatun16 Jan 2018 11:00 AM IST
      New Delhi: Glenmark Pharmaceuticals said it has received nod from Directorate General of Health Services, Central Drugs Standard Control Organisation,...
      Over 92 percent people do not trust healthcare system in India: Study

      Over 92 percent people do not trust healthcare system in India: Study

      Ruby Khatun Khatun16 Jan 2018 10:48 AM IST
      New Delhi: Over 92 percent people do not trust healthcare system in India, with the hospital being the most distrusted organization followed by Pharma...
      Bodhtree Consulting bags orders worth over Rs 50 crore

      Bodhtree Consulting bags orders worth over Rs 50 crore

      Ruby Khatun Khatun16 Jan 2018 10:30 AM IST
      Mumbai: Bodhtree Consulting Ltd, a leading IT consulting and software service provider announced that it has bagged orders worth over Rs 50 crore.The...
      LIC sells over 2 percent stake in Merck

      LIC sells over 2 percent stake in Merck

      Ruby Khatun Khatun16 Jan 2018 10:00 AM IST
      New Delhi: Life Insurance Corporation has sold a little over 2 percent stake in drug and chemical firm Merck Ltd through an open market...
      German watchdog calls for direct comparison of cancer immunotherapies

      German watchdog calls for direct comparison of cancer immunotherapies

      Ruby Khatun Khatun16 Jan 2018 9:30 AM IST
      FRANKFURT: Germany’s drug assessment body has criticized a lack of data directly comparing drugs in a promising new class of cancer immunotherapy,...
      NITI Aayog asked to revamp process of drug selection for price control

      NITI Aayog asked to revamp process of drug selection for price control

      Ruby Khatun Khatun15 Jan 2018 4:19 PM IST
      New Delhi: The system of selections of drugs for Price Control may now undergo a sea change as the government has asked the NITI Aayog to revamp the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok